Clinical Trial Update: Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating pembrolizumab in combination with radiation therapy for relapsed or refractory multiple myeloma; results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Emory University | Conditions: ISS Stage I Plasma Cell Myeloma, ISS Stage II Plasma Cell Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-09-04